Adlai Nortye Stock (NASDAQ: ANL) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 12.56K |
Day Range | - - - |
52 Wk Range | 3.01 - 19.30 |
Market Cap | $133.58M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 0.03% |
Days to Cover | 2.4 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Adlai Nortye (NASDAQ:ANL) through any online brokerage.
Other companies in Adlai Nortye’s space includes: Galectin Therapeutics (NASDAQ:GALT), CytomX Therapeutics (NASDAQ:CTMX), FibroGen (NASDAQ:FGEN), Tevogen Bio Holdings (NASDAQ:TVGN) and Adicet Bio (NASDAQ:ACET).
There is no analysis for Adlai Nortye.
There is no analysis for Adlai Nortye to provide a consensus price target.
The stock price for Adlai Nortye (NASDAQ: ANL) is $3.4912 last updated July 26, 2024 at 3:45 PM EDT.
There are no upcoming dividends for Adlai Nortye.
Adlai Nortye’s Q1 earnings are confirmed for Tuesday, August 13, 2024.
There is no upcoming split for Adlai Nortye.
Adlai Nortye is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.